CAS: 84-82-2 - 1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione
Formula:C7H7N5O2
InChI:InChI=1S/C7H7N5O2/c1-11-6(13)4-5(10-7(11)14)12(2)9-3-8-4/h3H,1-2H3
InChI key:InChIKey=SLGRAIAQIAUZAQ-UHFFFAOYSA-N
SMILES:O=C1N=C2C(=NC=NN2C)C(=O)N1C
- Synonyms:
- 1,5,6,7-Tetrahydro-1,6-dimethylpyrimidino[5,4-e]triazine-5,7-dione
- 1,6-Dimethyl-5,7-dioxo-1,5,6,7-tetrahydropyrimido[5,4-e]-as-triazine
- 84-82-2
- K4394
- NSC 67078
- Pkf 118-310
- Pkf118-310
- Pyrimido[5,4-e]-as-triazine-5,7(1H,6H)-dione, 1,6-dimethyl-
- Sid 4251194
- Toxoflavin
- See more synonyms
- Toxoflavine
- Xanthothricin
- Xanthotricin
- pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-dione, 1,6-dimethyl-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Toxoflavin REF: TM-T17142CAS: 84-82-2 | 99.7% | 88.00 €~453.00 € | Tue 07 May 24 | |
PKF118-310-D3 REF: TR-P572504CAS: 84-82-2 | - - - | 5,339.00 € | Tue 18 Jun 24 | |
PKF118-310 REF: TR-P572503CAS: 84-82-2 | - - - | 5,339.00 € | Tue 18 Jun 24 | |
PKF118-310 REF: 3D-AAA08482CAS: 84-82-2 | Min. 95% | To inquire | Mon 17 Jun 24 |
Toxoflavin
CAS:84-82-2
Toxoflavin (Xanthothricin) is an antagonist of transcription factor 4 (TCF4)/β-catenin complex. Toxoflavin also acts as …
Formula:
C7H7N5O2
Purity:
99.7%
Color and Shape:
Solid
Molecular weight:
193.16
Ref: TM-T17142
5mg | 88.00 € | |
10mg | 152.00 € | |
25mg | 301.00 € | |
50mg | 453.00 € | |
1ml*10 (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 7 May 2024
Ref: TR-P572504
25mg | 5,339.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
Ref: TR-P572503
250mg | 5,339.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
PKF118-310
CAS:84-82-2
PKF118-310 is a basic protein that has been shown to have significant cytotoxicity against the …
Formula:
C7H7N5O2
Purity:
Min. 95%
Molecular weight:
193.16 g/mol
Ref: 3D-AAA08482
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024